The tetradecapeptide somatostatin was cyclized by a combination of conventional and solid phase peptide synthesis methods, to a homodetic cyclic disulfide tetradecapeptide, Wy-40,391: The analog inhibits the release of growth hormone (GH) without affecting either insulin or glucagon secretion. A correlation between binding affinity to the receptors and specificity is suggested. 相似文献